DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Artículo científico (JournalArticle)
Tracing the evolutionary history of Ca2+-signaling modulation by human Bcl-2: Insights from the Capsaspora owczarzaki IP3 receptor ortholog
Recently, a functional IP3R ortholog (CO.IP3R-A) capable of IP3-induced Ca2+ release has been discovered in Capsaspora owczarzaki, a close unicellular relative to Metazoa. In contrast to mammalian IP3Rs, CO.IP3R-A is not modulated by Ca2+, ATP or PKA. Protein-sequence analysis revealed that CO.IP3R-A contained a putative binding site for anti-apoptotic Bcl-2, although Bcl-2 was not detected in Capsaspora owczarzaki and only appeared in Metazoa. Here, we examined whether human Bcl-2 could form a complex with CO.IP3R-A channels and modulate their Ca2+-flux properties using ectopic expression approaches in a HEK293 cell model in which all three IP3R isoforms were knocked out. We demonstrate that human Bcl-2 via its BH4 domain could functionally interact with CO.IP3R-A, thereby suppressing Ca2+ flux through CO.IP3R-A channels. The BH4 domain of Bcl-2 was sufficient for interaction with CO.IP3R-A channels. Moreover, mutating the Lys17 of Bcl-2's BH4 domain, the residue critical for Bcl-2-dependent modulation of mammalian IP3Rs, abrogated Bcl-2's ability to bind and inhibit CO.IP3R-A channels. Hence, this raises the possibility that a unicellular ancestor of animals already had an IP3R that harbored a Bcl-2-binding site. Bcl-2 proteins may have evolved as controllers of IP3R function by exploiting this pre-existing site, thereby counteracting Ca2+-dependent apoptosis., The work was supported by grants from the Research Foundation—Flanders (FWO) (G.0901.18N) and by the Research Council of the KU Leuven (C14/19/101). N.R. and H.I. are recipient of postdoctoral fellowships of the FWO; H.I. obtained a travel grant from the FWO to perform work in D.I.Y.'s laboratory. G.B. and D.I.Y. are part of the FWO Scientific Research Network CaSign (W0.019.17N). Work in D.I.Y.'s lab is supported by the National Institute of Dental and Craniofacial Research (National Institute of Health; grant DE014756). A.S-P. was supported by the European Research Council under the European Union's Horizon 2020 research and innovation program grant agreement No 851647, the Ministerio de Ciencia e Innovación, Centro de Excelencia Severo Ochoa (SEV-2016-0571) and the Agencia Estatal de Investigación., Peer reviewed
Project:
EC / H2020 851647
,
MINECO SEV-2016-0571